Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.84 |
| ▸ | TSHR | P16473 | 1/20 | 0.84 |
| ▸ | TTR | P02766 | 1/20 | 0.74 |
| ▸ | FDPS | P14324 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.63 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.63 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.63 |
| ▸ | ABAT | P80404 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21328335 | 0.96 | ALDH1A1 (0.85) | ALDH1A1TSHRTTRFDPSHPGD | |
| SCHEMBL26927383 | 0.93 | ALDH1A1 (0.79) | ALDH1A1TSHRTTRFDPSHPGD | |
| SCHEMBL7366005 | 0.92 | ALDH1A1 (0.84) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL5308959 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL29364994 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL1330962 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL25202 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TSHRTTRFDPSHPGD | |
| SCHEMBL27887208 | 0.89 | MAPT (0.71) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL29624454 | 0.89 | ALDH1A1 (0.96) | ALDH1A1TSHRTTRFDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL28205798 | 0.89 | ALDH1A1 (0.96) | ALDH1A1TSHRTTRFDPSHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113563166-B | Synthesis method of vanillyl alcohol ether | 珠海市柏瑞医药科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| EP-2861084-A1 | NEUTRALLY BUOYANT INGESTIBLE COMPOSITIONS | Adam, Georgius, Abidal (US) | 2015-04-22 | — | — | EP | claimed |
| WO-2013187897-A1 | NEUTRALLY BUOYANT INGESTIBLE COMPOSITIONS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-12-19 | — | — | WO | claimed |
| CN-118420442-B | Method for preparing vanillin by reducing vanillin with silicon powder | 天津市职业大学 | 2024-09-13 | — | — | CN | disclosed |
| CN-118420442-A | Method for preparing vanillin by reducing vanillin with silicon powder | 天津市职业大学 | 2024-08-02 | — | — | CN | disclosed |
| WO-2023238600-A1 | EGG FLAVORING AGENT, METHOD FOR IMPARTING EGG FLAVOR TO FOODS AND DRINKS, METHOD FOR PRODUCING FOODS AND DRINKS HAVING EGG FLAVOR, AND FOODS AND DRINKS | 株式会社Ｊ－オイルミルズ | 2023-12-14 | — | — | WO | disclosed |
| CN-113563166-B | Synthesis method of vanillyl alcohol ether | 珠海市柏瑞医药科技有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-110479325-A | A kind of catalyst and preparation method thereof for synthesizing guaiacol | UNIV SHANGHAI | 2019-11-22 | — | — | CN | disclosed |
| CN-110312700-A | Method for purifying natural vanillin | 罗地亚经营管理公司 | 2019-10-08 | — | — | CN | disclosed |
| US-20190275027-A1 | Bis-Benzyl-Tetrahydroisoquinoline Derivatives As Therapeutics For Filovirus | SOUTHWEST RESEARCH INSTITUTE | 2019-09-12 | — | — | US | disclosed |
| CN-107543838-B | A kind of adulterated magnetic resonance detection method for planting butter cream in dilute cream | 北京市食品安全监控和风险评估中心（北京市食品检验所） | 2019-07-26 | — | — | CN | disclosed |
| WO-2011056935-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| WO-2010117740-A2 | ENHANCED FORMULATIONS, COMPOSITIONS AND METHODS FOR PEST CONTROL | TYRATECH, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| CN-101416773-A | Method for increasing the quality of flavoring essences for tobacco using oak | WUHAN TOBACCO GROUP LTD (CN) | 2009-04-29 | — | — | CN | disclosed |
| CN-1316977-C | Stable brivudine topical formulations | MENARINI RICERCHE SPA (IT) | 2007-05-23 | — | — | CN | disclosed |
| CN-1604782-A | Stabilized brivudine topical formulations | MENARINI RICERCHE SPA (IT) | 2005-04-06 | — | — | CN | disclosed |
| EP-1463513-A1 | STABILIZED BRIVUDINE TOPICAL FORMULATIONS | Menarini Ricerche S.p.A. (IT) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003051375-A1 | STABILIZED BRIVUDINE TOPICAL FORMULATIONS | MENARINI RICERCHE S.P.A. (IT) | 2003-06-26 | — | — | WO | disclosed |
| US-5895657-A | MIXTURE WITH ETHYL VANILLIN AND SOLVENT; FOODS, PERFUMES, COSMETICS, AND FLAVORS | RHONE-POULENC CHIMIE (FR) | 1999-04-20 | — | — | US | disclosed |
| US-5128253-A | Sufhydryl compound | KRAFT GENERAL FOODS, INC. (US) | 1992-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190275027-A1 | Bis-Benzyl-Tetrahydroisoquinoline Derivatives As Therapeutics For Filovirus | TREH, TTN, TSN | ALDH1A1 2748/4885TSHR 1544/4885TTR 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.